RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
Ausgabe 07 · Volume 78 · 1997 DOI: 10.1055/s-008-40700
Thrombosis in the young
001
007
013
Gene therapy for hemophilia: hopes and reality for the children of the new century
031
Thrombopoietin
042
Hemostatic predictors of thrombosis: the contribution of epidemiology
053
Platelet-leukocyte-endothelial cell cross-talk
065
The protein C pathway
070
Antiphospholipid antibodies
Integrin signalling and vascular function
083
088
096
Understanding the initiation of blood coagulation
101
112
Venous thromboembolism and cancer, a two-way clinical association
121
126
133
Molecular defects in rare bleeding disorders
145
Antithrombotic therapy of acute stroke
Pathogenesis of atherosclerosis: a l997 update
Clinical trials with anti IIb/IIIa inhibitors in acute coronary syndromes
205
210
214
Platelets and signal transduction
220
226
234
PLENARY LECTURE – Shirley Johnson Lecture
PLENARY LECTURE – Marion Barnhart
247
New recombinant products in the treatment of hemophilias
261
Recombinant Factor IX
- Volltext
- PDF (1176 kb)
Platelet membrane glycoproteins
266
Platelet GPIb-V-IX Complex
- Volltext
- PDF (1022 kb)
Current status of activation markers in ischemic heart disease
276
280
Tumors and fibrinolysis
285
Thrombophilia as a multigenic disorder
297
Leukocyte-endothelial cell interactions
302
306
310
Oral contraceptives and thrombotic disease
327
334
Molecular basis of inherited thrombophilia: from genedefects to disease
339
351
Protein S Deficiency
- Volltext
- PDF (1412 kb)
Clinical trials of direct thrombin inhibitors
357
364
Controversial issues in oral anticoagulant therapy
Thrombomodulin
386
392
Cytokines and thrombosis
401
406
PLENARY LECTURE – Sol Sherry Lecture
420
PLENARY LECTURE – Wright-Schulte Lecture
Platelet activation by collagen
434
439
Pathophysiology of von Willebrand factor
451
Genetic determinants of the risk of arterial thrombosis
457
Tissue factor pathway inhibitor: a protein in search for a disease
New aspects of APC resistance
478
483
Clinical use of low molecular weight heparins
Metallo proteinases and vascular biology
Crystal structure of coagulation proteins
501
512
Hyperhomocysteinemia and thrombosis
520
523
Transgenic production of hemostasis proteins
537
The drug trials that have influenced our clinical practice in the treatment of thrombosis
548
553
558
New treatments of von Wiltebrand disease
566
571
Thrombin and its modulation
590
Structure and mechanism of action of vitamin K-dependent gamrnt-ctrboxylase
595
Plenary Lecture
605
Bleeding and thrombosis in myeloproliferative disorders
622
New aspects of arachidonic acid metabolism
627
Epidemiology of inherited thrombophilia
631
Factor VIII and factor IX inhibitors
641
Factor VIII Inhibitors
- Volltext
- PDF (1172 kb)
Plasminogen activator inhibitor I (PAI-1)
652
Special Symposium
661
Fibrin Tissue Adhesives
- Volltext
- PDF (1254 kb)
Animal models of thrombotic and hemorrhagic disorders
667
Angiogenesis
Prevention and treatment of deep vein thrombosis
689
Lessons from gene knock-out technology
Disorders of hemostasis in childhood
710
Newer antithrombotic agents
730
736
742
Thrombolytic Therapy
- Volltext
- PDF (1042 kb)
Tissue factor
747
755
759